You are currently browsing the archive for the StrataGent category.

Innovance client, StrataGent Life Sciences has just closed a $16M round of funding. I’ve been involved with this company since my Stanford days, and am really thrilled to be able to help them develop and find success.

Congratulations StrataGent!

Innovance has begun working with a company called StrataGent life sciences. StrataGent is developing a needle-free device that painlessly delivers drug with an onset comparable to injection. The company’s core technology is a pulsed liquid microjet that was invented at Stanford University. Their device works by creating a small, high pressure jet of liquid that penetrates the outer layer of the skin and precisely deposits drugs into the epidermis (the top layer of skin), enabling rapid absorption by the body, while avoiding the pain receptors that lie below in the dermis. The device can be used to deliver injectable drugs without requiring a change in formulation

I will be helping drive the company’s strategy by identifying which markets to apply the technology to, evaluating competitive threats and clarifying the regulatory and reimbursement path.

To read more about the device visit: